8-HydroxyapigeninCAS# 41440-05-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 41440-05-5 | SDF | Download SDF |
PubChem ID | 5281665 | Appearance | Yellow crystalline powder |
Formula | C15H10O6 | M.Wt | 286.239 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | Isoscutellarein | ||
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5,7,8-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one | ||
SMILES | C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)O)O | ||
Standard InChIKey | NXHQVROAKYDSNW-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C15H10O6/c16-8-3-1-7(2-4-8)12-6-10(18)13-9(17)5-11(19)14(20)15(13)21-12/h1-6,16-17,19-20H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
8-Hydroxyapigenin Dilution Calculator
8-Hydroxyapigenin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.4936 mL | 17.4679 mL | 34.9358 mL | 69.8717 mL | 87.3396 mL |
5 mM | 0.6987 mL | 3.4936 mL | 6.9872 mL | 13.9743 mL | 17.4679 mL |
10 mM | 0.3494 mL | 1.7468 mL | 3.4936 mL | 6.9872 mL | 8.734 mL |
50 mM | 0.0699 mL | 0.3494 mL | 0.6987 mL | 1.3974 mL | 1.7468 mL |
100 mM | 0.0349 mL | 0.1747 mL | 0.3494 mL | 0.6987 mL | 0.8734 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 5-Benzoylpentanoic acid
Catalog No.:BCC8740
CAS No.:4144-62-1
- Cirsilineol
Catalog No.:BCN2560
CAS No.:41365-32-6
- Stachydrine hydrochloride
Catalog No.:BCN5332
CAS No.:4136-37-2
- 1,3,6-Trihydroxy-5-methoxyxanthone
Catalog No.:BCN3454
CAS No.:41357-84-0
- Anhydrotuberosin
Catalog No.:BCN5468
CAS No.:41347-49-3
- Etodolac
Catalog No.:BCC4428
CAS No.:41340-25-4
- NP118809
Catalog No.:BCC1807
CAS No.:41332-24-5
- Isorhamnetin 3-sophoroside-7-rhamnoside
Catalog No.:BCN1446
CAS No.:41328-75-0
- BAM (8-22)
Catalog No.:BCC5806
CAS No.:412961-36-5
- Alfacalcidol
Catalog No.:BCC4962
CAS No.:41294-56-8
- TIC10
Catalog No.:BCC3906
CAS No.:41276-02-2
- 4-IPP
Catalog No.:BCC6023
CAS No.:41270-96-6
- 5-Heptadecylresorcinol
Catalog No.:BCN4750
CAS No.:41442-57-3
- ODQ
Catalog No.:BCC6829
CAS No.:41443-28-1
- (-)-N-Methylsedridine
Catalog No.:BCN5469
CAS No.:41447-15-8
- (+)-N-Methylallosedridine
Catalog No.:BCN5470
CAS No.:41447-16-9
- Phalaenopsine Is
Catalog No.:BCN2016
CAS No.:41451-64-3
- Onetine
Catalog No.:BCN2102
CAS No.:41451-67-6
- Bruceantin
Catalog No.:BCN7618
CAS No.:41451-75-6
- Turkesterone
Catalog No.:BCN2363
CAS No.:41451-87-0
- Belinostat (PXD101)
Catalog No.:BCC2153
CAS No.:414864-00-9
- 3-Amino-1-phenyl-2-pyrazolin-5-one
Catalog No.:BCC8605
CAS No.:4149-06-8
- 12-Oleanene-3,6-diol
Catalog No.:BCN3903
CAS No.:41498-79-7
- Daturaolone
Catalog No.:BCN3904
CAS No.:41498-80-0
Virtual Screening of Indonesian Herbal Database as HIV-1 Protease Inhibitor.[Pubmed:24616554]
Bioinformation. 2014 Feb 19;10(2):52-5.
HIV-1 (Human immunodeficiency virus type 1)s infection is considered as one of most harmful disease known by human, the survivability rate of the host reduced significantly when it developed into AIDS. HIV drug resistance is one of the main problems of its treatment and several drug designs have been done to find new leads compound as the cure. In this study, in silico virtual screening approach was used to find lead molecules from the library or database of natural compounds as HIV-1 protease inhibitor. Virtual screening against Indonesian Herbal Database with AutoDock was performed on HIV-1 protease. From the virtual screening, top ten compounds obtained were 8-Hydroxyapigenin 8-(2",4"-disulfatoglucuronide), Isoscutellarein 4'-methyl ether, Amaranthin, Torvanol A, Ursonic acid, 5-Carboxypyranocyanidin 3-O-(6"-O-malonyl-beta-glucopyranoside), Oleoside, Jacoumaric acid, Platanic acid and 5-Carboxypyranocyanidin 3-O-beta-glucopyranoside.